Middle East and Africa Hair Loss Treatment Products Market Research Report – Segmentation By Product Type (Shampoos & Conditioners, Serums & Oils, Tablets & Supplements, Hair Masks & Topical Creams, Laser Devices & Tools); By Gender (Men, Women); and Region - Size, Share, Growth Analysis | Forecast (2025– 2030)

The Middle East and Africa Hair Loss Treatment Products Market was valued at USD 11.07 billion in 2024 and is projected to reach a market size of USD 13.73 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 4.4%.   

The Middle East and Africa hair loss treatment products market is driven by rising grooming and self-care awareness among both men and women, and a growing preference for natural, herbal-based solutions due to concerns over chemical side effects.

. Based on Service Provider, the Middle East and Africa Hair Loss Treatment Products Market is segmented into material manufacturers, Raw Material Suppliers, Lab information management systems, Distributors & Wholesalers, End-to-End Solution Providers.

UAE & Saudi Arabia are the most dominant regions for the Middle East and Africa Hair Loss Treatment Products Market

Daiichi Sankyo, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Merck & Co., Shiseido, Cipla, Dr. Reddy’s Laboratories, Taisho Pharmaceutical, Lexington International, Aclaris Therapeutics, Concert Pharmaceuticals, and Cellmid are the key players in the Middle East and Africa Hair Loss Treatment Products Market.